AKT activation can occur independently of RTK signaling, as a result of the mutation of the tumor suppressor PTEN, a phosphatase that converts PIP3 to PIP2, and is frequently mutated in a high proportion of primary and metastatic tumors, including CRPC. The gene discussed is AKT1; the disease is metastatic neoplasm.